Alpha Tau Medical (DRTS) Assets (2020 - 2026)
Alpha Tau Medical (DRTS) posted Assets of $108.8 million for Q1 2026, up 2.95% sequentially from $105.7 million in Q4 2025, and up 34.41% YoY from $80.9 million in Q1 2025.
Alpha Tau Medical (DRTS) Assets (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Assets for 7 years, with the latest figure at $108.8 million in Q1 2026.
- Quarterly Assets rose 34.41% year-over-year to $108.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $108.8 million (up 34.41% YoY) and the FY2025 annual result came in at $105.7 million, up 22.56% from the prior year.
- Assets grew to $108.8 million in Q1 2026 per DRTS's latest filing, from $105.7 million in the prior quarter.
- Over five years, Assets peaked at $124.0 million in Q2 2022 and troughed at $80.9 million in Q1 2025.
- A 5-year average of $106.5 million and a median of $107.4 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets surged 184.61% in 2022, then retreated 21.0% in 2025.
- Over 5 years, Assets stood at $120.1 million in 2022, then decreased by 10.62% to $107.4 million in 2023, then decreased by 19.73% to $86.2 million in 2024, then advanced by 22.56% to $105.7 million in 2025, then gained by 2.95% to $108.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $108.8 million, $105.7 million, and $104.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | 134.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134.25 Mn |
| Mar 31, 2026 | 108.77 Mn |
| Dec 31, 2025 | 105.65 Mn |
| Sep 30, 2025 | 104.69 Mn |
| Jun 30, 2025 | 110.95 Mn |
| Mar 31, 2025 | 80.93 Mn |
| Dec 31, 2024 | 86.20 Mn |
| Sep 30, 2024 | 90.73 Mn |
| Jun 30, 2024 | 96.05 Mn |
| Mar 31, 2024 | 102.44 Mn |
| Dec 31, 2023 | 107.39 Mn |
| Sep 30, 2023 | 106.38 Mn |
| Jun 30, 2023 | 111.21 Mn |
| Mar 31, 2023 | 116.05 Mn |
| Dec 31, 2022 | 120.15 Mn |
| Sep 30, 2022 | 119.37 Mn |
| Jun 30, 2022 | 123.98 Mn |
| Mar 31, 2022 | 119.04 Mn |
| Dec 31, 2021 | 42.22 Mn |
| Dec 31, 2020 | 52.99 Mn |